enGene Therapeutics (ENGN) Non Operating Interest Expenses (2023 - 2026)
enGene Therapeutics' Non Operating Interest Expenses was $843,000 in fiscal Q3 2026 (quarter ended Jul 31, 2026), up 11.2% from $758,000 a year earlier and up 13.2% from the prior quarter.
enGene Therapeutics (ENGN) Non Operating Interest Expenses (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, enGene Therapeutics' Non Operating Interest Expenses was $3.07 million through Jul 31, 2026, up 2.3% year-over-year; for FY2025 (ended Oct 31, 2025), it was $2.99 million, up 7.0% from FY2024.
- Non Operating Interest Expenses shows a three-year compound annual growth rate of 28.1% (FY2022 to FY2025).
- In earlier fiscal years, Non Operating Interest Expenses was $2.8 million in FY2024 (-43.5%), $4.95 million in FY2023 (+248.1%) and $1.42 million in FY2022.
- The fiscal Q3 2026 figure marks the highest quarterly Non Operating Interest Expenses since fiscal Q4 2023.
- Compared with a year earlier, Non Operating Interest Expenses was higher in five of the last eight quarters, with growth averaging 1.2%.
- The best year-over-year quarter for Non Operating Interest Expenses over five years was fiscal Q1 2025 (growth of 33.6%); the worst was fiscal Q1 2024 (a decline of 52.1%).
- Per Business Quant data, ENGN's Non Operating Interest Expenses in the three fiscal quarters before Q3 2026 was $745,000 (Q2 2026), $732,000 (Q1 2026) and $750,000 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | enGene Therapeutics | 134.03 Mn | 134.03 Mn | - | 843,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 843,000.00 |
| Apr 30, 2026 | 745,000.00 |
| Jan 31, 2026 | 732,000.00 |
| Oct 31, 2025 | 750,000.00 |
| Jul 31, 2025 | 758,000.00 |
| Apr 30, 2025 | 734,000.00 |
| Jan 31, 2025 | 752,000.00 |
| Oct 31, 2024 | 756,000.00 |
| Jul 31, 2024 | 751,000.00 |
| Apr 30, 2024 | 728,000.00 |
| Jan 31, 2024 | 563,000.00 |
| Oct 31, 2023 | 1.16 Mn |
| Jul 31, 2023 | 1.44 Mn |
| Apr 30, 2023 | 1.18 Mn |
| Jan 31, 2023 | 1.18 Mn |
enGene Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();